Cifurtilimab (SEA-CD40) is a humanised monoclonal antibody acting as a CD40 agonist. It enhances binding to activated FcgammaRIIIa, exhibiting anticancer activity for treating pancreatic cancer, advanced solid tumours, and lymphoma.
Purity:
95.10%
CAS Number:
[1629760-27-5]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted